Bill journey · stage 2 of 5
Under committee review
What it doesSummary reported to house with amendment(s) (Jun 12, 2018)
This bill requires the Centers for Medicare & Medicaid Services to develop guidance for states on neonatal abstinence syndrome services, including coverage options under Medicaid and the Children's Health Insurance Program (CHIP). The Government Accountability Office must also study Medicaid coverage gaps for pregnant and postpartum women with substance-use disorders.
What just happenedJun 12, 2018
Placed on the Union Calendar, Calendar No. 565.
Who’s behind it
Placed on the Union Calendar, Calendar No. 565.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-730.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-730.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
This bill requires the Centers for Medicare & Medicaid Services to develop guidance for states on neonatal abstinence syndrome services, including coverage options under Medicaid and the Children's Health Insurance Program (CHIP). The Government Accountability Office must also study Medicaid coverage gaps for pregnant and postpartum women with substance-use disorders.
This bill allows states to receive federal payment under Medicaid for outside services that are provided to pregnant and postpartum women who are substance use disorder patients at institutions for mental diseases. State Medicaid programs may also cover residential pediatric recovery center services for infants with neonatal abstinence syndrome.